The National Institute of Nursing Research, with private-sector support from Nippon Zoki Pharmaceuticals Co., Ltd., is conducting two clinical trials on the investigational drug, Neurotropin, for the treatment of complex regional pain syndrome and fibromyalgia. Currently, no effective drug treatments exist for these chronic pain disorders. The Foundation for NIH raised $300,000 from the private sector to support this project.

Partners
Nippon Zoki Pharmaceuticals Co., Ltd.